HomeAbout UsContact Us1-800-477-6037
Medical Device Daily
Archive Search

User ID


Forgot password

Remember my login

New User ?

Products & Services
Medical Device Daily
Medtech Resources
BioWorld Executive Compensation Report 2014
MDD State of the Industry Report 2013
BioWorld and Medical Device VC Directory 2012
MDD Perspectives
BioWorld Today
Biotech Resources
Perspectives Blog
PMA and 501(k) Approvals

Today's Headlines

EU reaches accord on stricter regulations for medtech, IVDs

PARIS — The European Union reached agreement on the reform of regulations for the CE mark that governs the commercialization of medical devices and in vitro diagnostic tests (IVDs) in the world's second-largest market.

Boston Scientific flies the W flag

It took 10 years but Boston Scientific (BSX) may have finally overcome its ill-advised 2006 Guidant acquisition. The company's shares hit a decade high Wednesday, at one point spiking nearly 12 percent to $22.05 after knocking its first quarter sales out of the park. (MDD Perspectives)

Growing evidence supports clinical potential of new cancer tests

With a market opportunity in the billions (as much as $20 billion by some estimates), diagnostic companies are rushing the liquid biopsy floodgates with new tests designed to make finding and monitoring cancer as easy as a blood draw or urine sample. This week, in a two-part series, Medical Device Daily will explore both the business opportunities and the clinical potential of this growing market.

MDD Home   |   About MDD   |   Contact Us   |   Copyright Notices   |   Terms of Use   |   Privacy Statement   |   Free Alerts

Part of Thomson Reuters
thomsonreuters.com | lifesciences.thomsonreuters.com | BioWorld.com | medicaldevicedaily.com